Cardlytics, Inc. (NASDAQ:CDLX) Receives Consensus Recommendation of “Hold” from Brokerages

Cardlytics, Inc. (NASDAQ:CDLX) has been assigned a consensus recommendation of “Hold” from the seven research firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $6.42.

CDLX has been the topic of a number of recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th. Lake Street Capital dropped their price target on shares of Cardlytics from $5.00 to $3.00 and set a “hold” rating on the stock in a research note on Thursday, March 13th. Finally, Evercore ISI dropped their price target on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a research note on Thursday, March 13th.

Cardlytics Stock Performance

Shares of Cardlytics stock opened at $2.33 on Friday. The firm has a market cap of $121.36 million, a PE ratio of -0.38 and a beta of 1.62. The firm’s 50-day simple moving average is $2.91 and its 200-day simple moving average is $3.45. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. Cardlytics has a 1 year low of $1.77 and a 1 year high of $20.52.

Insider Buying and Selling at Cardlytics

In other news, CEO Amit Gupta sold 15,160 shares of the stock in a transaction that occurred on Friday, January 24th. The shares were sold at an average price of $3.92, for a total value of $59,427.20. Following the completion of the transaction, the chief executive officer now directly owns 215,494 shares in the company, valued at $844,736.48. This trade represents a 6.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Alexis Desieno sold 8,854 shares of the stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18. Following the completion of the transaction, the chief financial officer now owns 121,976 shares of the company’s stock, valued at $447,651.92. This trade represents a 6.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 111,454 shares of company stock worth $391,864. 4.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Two Sigma Advisers LP boosted its holdings in Cardlytics by 44.1% during the fourth quarter. Two Sigma Advisers LP now owns 36,900 shares of the company’s stock worth $137,000 after buying an additional 11,300 shares in the last quarter. Two Sigma Investments LP boosted its holdings in Cardlytics by 12.5% during the fourth quarter. Two Sigma Investments LP now owns 94,901 shares of the company’s stock worth $352,000 after buying an additional 10,508 shares in the last quarter. ProShare Advisors LLC bought a new stake in Cardlytics during the fourth quarter worth approximately $43,000. Millennium Management LLC bought a new stake in Cardlytics during the fourth quarter worth approximately $535,000. Finally, D. E. Shaw & Co. Inc. boosted its holdings in Cardlytics by 97.4% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,131,505 shares of the company’s stock worth $4,198,000 after buying an additional 558,235 shares in the last quarter. 68.10% of the stock is currently owned by institutional investors.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.